Liver and Pancreatic Involvement in Children with Multisystem Inflammatory Syndrome Related to SARS-CoV-2: A

Antonietta Giannattasio1, Marco Maglione1, Carolina D'Anna1

  • 1Pediatric Emergency Unit, Santobono-Pausilipon Children's Hospital, AORN, 80130 Naples, Italy.

Insights

Liver and pancreatic issues are common in children with Multisystem Inflammatory Syndrome (MIS-C) due to SARS-CoV-2. While often mild, these conditions require careful monitoring for potential complications and recovery.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Gastroenterology

Background:

  • Multisystem Inflammatory Syndrome related to SARS-CoV-2 (MIS-C) can affect various organs in children.
  • Liver and pancreatic involvement in MIS-C is not well-understood.
  • Understanding these complications is crucial for managing pediatric COVID-19 sequelae.

Purpose of the Study:

  • To investigate the prevalence of acute liver injury (ALI) and pancreatic injury in children with MIS-C.
  • To analyze the correlation between liver/pancreatic involvement and clinical outcomes in MIS-C patients.
  • To describe the clinical, laboratory, and imaging features of affected children.

Main Methods:

  • Prospective cohort study of 55 children diagnosed with MIS-C.
  • Collection of demographic, clinical, laboratory, and imaging data at admission and during hospitalization.
  • Analysis of acute liver injury (ALI) and pancreatic enzyme levels (lipase).

Main Results:

  • At admission, 16 patients had ALI and 5 had elevated lipase; during observation, 10 more developed ALI and 19 more had elevated pancreatic enzymes.
  • ALI was associated with older age (p=0.0004).
  • Pancreatic involvement correlated with a longer hospital stay (p=0.004), and ALI onset was earlier than pancreatic enzyme elevation (p=0.035).

Conclusions:

  • Liver and pancreatic involvement are frequently observed in pediatric MIS-C patients.
  • These involvements are typically mild and associated with a complete recovery.
  • Early identification and monitoring of hepatic and pancreatic changes are important in MIS-C management.